7–8 December 2017 For More information contact: ExL Events Phone: 866-207-6528 Email: Registration@exlevents.com   “Improve the Management...

share

Champions Oncology, a company engaged in the development and sale of advanced technology solutions and products to personalize...

share

Teva Pharmaceutical Industries announced the launch of generic Axiron®1 (testosterone) topical solution CIII, 30 mg/1.5 mL, in the...

share

A new consortium, led by Oxford BioMedica, will take part in a two-year, £2m project focused on gene...

share

Roche announced results from the global phase III ALUR study showing that Alecensa® significantly reduced the risk of...

share

Midatech Pharma has announced the submission of a clinical trial application (CTA) for a first in human study...

share

ViraCyte, LLC, a clinical stage biopharmaceutical company developing cellular immunotherapies for severe infections, announced publication of positive data...

share

Sun Pharma and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab. The agreement was entered into by...